Navigation Links
Mediware Reports Second Quarter Fiscal 2008 Results
Date:2/5/2008

Teleconference Call Scheduled For 10:00am EST Today

LENEXA, Kan., Feb. 5 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc. (Nasdaq: MEDW), a provider of ClosedLoop(TM) clinical systems for blood and medication management, reported total revenue for the second quarter of fiscal year 2008 of $8,659,000 compared to $11,262,000 in the comparable quarter in fiscal year 2007. Net loss for the quarter was $337,000, or a loss of four cents per fully diluted share, compared to net income of $905,000, or eleven cents per fully diluted share in the comparable quarter of fiscal year 2007.

For the six-month period ended December 31, 2007, Mediware reported total revenue of $19,403,000 compared to $19,737,000 in the comparable period in fiscal year 2007. Net income for the six months ended December 31, 2007 was $126,000, or one cent per fully diluted share, compared to net income of $1,069,000, or thirteen cents per fully diluted share in the comparable period of fiscal year 2007. The six month results for Fiscal 2008 were hampered by a $225,000 non cash write-off of certain deferred tax assets and a cash charge of $377,000 associated with the organizational restructuring announced in July 2008.

"As anticipated, we experienced reduced revenue due to the pipeline gap following the completion of the blood management sunset program," said Kelly Mann, Mediware's president and chief executive officer. "The quarter's performance was also impacted by delays in contracting for medication management products due to the complex sales environment. However, as we continue to refresh our sales pipeline, we are encouraged that our year to date revenue is comparable to last year's record levels."

Mann Continues: "Despite our quarterly performance, I am pleased with the progress we are making with the introduction of new products, including MediREC, IMS, BloodSafe, and our extension to biologics management. We believe each of these products presents substantial opportunities for future growth."

Among the quarter's highlights:

-- Blood donor solution capabilities were strengthened through the $5.5

million acquisition of IMS.

-- Service revenues increased to $6.6 million primarily as a result of

implementation services associated with blood management sales from

previous quarters.

-- Implementation services backlog remains strong at approximately $8

million.

-- Solidified launch plans to introduce new solutions in 2008 for

biologics management as well as a hosted medication management platform

to deliver 'on demand' capabilities to smaller acute and behavioral

health facilities.

"I believe we are building a solid foundation for future growth and I am excited about the road ahead," said Mann. "We have an enviable customer base, a very strong balance sheet, and are introducing new products and strategies to fuel future growth and expand our presence in our target markets."

Mediware will host a teleconference call today at 10:00 am Eastern Time (9:00 am Central Time) to discuss the results. There will be a question-and- answer session directly following the presentation of the results.

To participate in the teleconference, please call toll-free 888-869-1189 (direct dial 706-643-5902) five minutes before the scheduled start in order to register for the call. The conference ID is: 32798410. You may also register in advance of the call online by going to: http://www.directeventreg.com/registration/event/32798410

A replay of the call will be available after the call's completion for 5 days at 800-642-1687 (direct dial 706-645-9291). The conference ID is: 32798410.

Mediware Information Systems, Inc.

Income (loss) Statement Highlights

(in thousands, unaudited):

Three Months Ended Six Months Ended

December 31, December 31,

2007 2006 2007 2006

System Sales $2,032 $4,890 $6,222 $7,213

Services 6,627 6,372 13,181 12,524

Total Revenue 8,659 11,262 19,403 19,737

Expenses 9,469 10,103 19,381 18,542

Operating Income (loss) (810) 1,159 22 1,195

Net Income (loss) $(337) $905 $126 $1,069

Earnings (loss) Per

Share - Diluted $(0.04) $0.11 $0.01 $0.13

Mediware Information Systems, Inc.

Balance Sheet Highlights

(in thousands, unaudited):

As of

December 31,

2007 2006

Cash and Cash Equivalents $ 20,949 $ 20,974

Working Capital $ 20,706 $ 21,396

Stockholders' Equity $ 42,402 $ 40,015

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at http://www.mediware.com.

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

Contact: Thomas Redington

203/222-7399

212/926-1733

http://www.redingtoninc.com

Mark Williams

Chief Financial Officer, Mediware

913 307-1000

http://www.mediware.com


'/>"/>
SOURCE Mediware Information Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Additional Top Tier Institutions Implement Mediwares HCLL(TM) Transfusion Management Software
4. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
5. Mediwares Transfusion Management Software Adopted by Four Additional Tenet Hospitals
6. Texas Health and Human Services Commission Adopts Mediwares ClosedLoop(TM) Medication Management Strategy
7. Mediware Completes Acquisition of Integrated Marketing Solutions
8. Mediware to Report Second Quarter 2008 Financial Results on Tuesday, February 5th
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... The doctors at Wall Centre Dental are now expanding ... and require sedation to receive dental care. The doctors offer three treatment options to ... cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental is ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients ... that achieves results in a fraction of the time as traditional braces – ... Significance Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
Breaking Medicine Technology: